Rejuvenation Research · 2016 · 15 citations · 41 references
MedicineEndocrinologyPharmacologyReproductive EndocrinologyReproductive MedicineReproductive PhysiologyAndrogen PhysiologyHormonal InfluencesOvarian PhysiologyPolycystic Ovary SyndromeReproductive PharmacologyBody Weight RegulationMenstrual Cycle EndocrinologyPolycystic Ovary Syndrome TreatmentTraditional Herbal FormulationsTraditional Herbal MedicineUterus Function
A traditional herbal prescription Kyung-Ok-Ko (KOK), composed of Rehmannia glutinosa Liboschitz var. purpurae , Lycium chinense , Aquilaria agallocha , Poria cocos , Panax ginseng , and honey, has been widely used in Oriental medicine as an invigorant for age-related diseases, such as amnesia and stroke. However, the beneficial value of KOK on uterine dysfunction related to hyperandrogenism is largely unknown. We investigated the effect of KOK (2.0 g/kg/day, per os) on endometrial abnormalities in a dehydroepiandrosterone (DHEA, subcutaneous)-induced polycystic ovary syndrome (PCOS) rat model. Preadministration of KOK significantly ( p <0.05) decreased the elevated body weight, uterus weight, and endometrial thickness by PCOS induction, corresponding to reduced apoptosis and the infiltration of immune cells (CD4 + T cells, CD8 + T cells, and macrophages) in the endometrium. These results were associated with reduced mRNA expression of interleukin (IL)-1β, IL-6, IL-8, and matrix metalloproteinase-3 and increased mRNA expression of IGF-β1, transforming growth factor (TGF)-β, TGF-β1, and vascular endothelial growth factor in the uterus after DHEA injection. These multiple effects of KOK may synergistically prevent the development of endometrial abnormalities in DHEA-induced hyperandrogenism via anti-inflammatory action, indicating that KOK has preventive and therapeutic potential for suppressing PCOS.
41
A call for transparent reporting to optimize the predictive value of preclinical research
Story C. Landis, Susan Amara, Khusru Asadullah et al. · Nature · 2012 · 1.2K citations · Full text